CCM
AMGN icon

CrestPoint Capital Management’s Amgen AMGN Stock Holding History

CrestPoint Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$1.46M Hold
8,400
– – 0.81% 37
2017
Q3 		$1.57M Sell
8,400
-1,200
-13% -$213K 0.7% 40
2017
Q2 		$1.65M Buy
9,600
+400
+4% +$65.1K 0.78% 33
2017
Q1 		$1.51M Buy
9,200
+1,200
+15% +$199K 0.72% 40
2016
Q4 		$1.17M Sell
8,000
-900
-10% -$135K 0.59% 55
2016
Q3 		$1.49M Sell
8,900
-5,600
-39% -$947K 0.76% 33
2016
Q2 		$2.21M Sell
14,500
-1,200
-8% -$187K 1.17% 10
2016
Q1 		$2.35M Sell
15,700
-5,200
-25% -$773K 1.28% 9
2015
Q4 		$3.39M Buy
20,900
+100
+0.5% +$15.7K 1.92% 4
2015
Q3 		$2.88M Buy
20,800
+3,700
+22% +$583K 1.65% 8
2015
Q2 		$2.63M Sell
17,100
-100
-0.6% -$16K 1.39% 8
2015
Q1 		$2.75M Buy
17,200
+12,400
+258% +$1.95M 1.43% 7
2014
Q4 		$765K Buy
4,800
+100
+2% +$15.6K 0.42% 90
2014
Q3 		$660K Hold
4,700
– – 0.4% 99
2014
Q2 		$556K Sell
4,700
-200
-4% -$23.2K 0.32% 108
2014
Q1 		$604K Sell
4,900
-1,300
-21% -$158K 0.38% 105
2013
Q4 		$707K Buy
+6,200
New +$705K 0.47% 81

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CrestPoint Capital Management's AMGN Position: Q4 2017 in Review

CrestPoint Capital Management held its Amgen (AMGN) position steady in Q4 2017 at 8,400 shares worth $1.46M. The position accounts for 0.81% of the portfolio, ranked #37.

CrestPoint Capital Management first reported a position in AMGN in Q4 2013 and has held it in 17 quarters since. The position peaked at $3.39M in Q4 2015. 1,735 funds tracked by Wall St. Rank hold AMGN as of Q4 2017.

  • CrestPoint Capital Management held 8,400 shares of Amgen worth $1.46M as of Q4 2017.
  • CrestPoint Capital Management left its Amgen share count unchanged in Q4 2017.
  • Amgen made up 0.81% of CrestPoint Capital Management's portfolio in Q4 2017, its #37 holding.
  • CrestPoint Capital Management first reported a position in Amgen in Q4 2013 and has held it in 17 quarters since.
  • CrestPoint Capital Management's Amgen position peaked at $3.39M in Q4 2015.
  • 1,735 funds tracked by Wall St. Rank held Amgen as of Q4 2017.

Based on CrestPoint Capital Management's 13F filing for Q4 2017, filed 17 Jan 2018.